Meghmani Organics growth ratios

·ChemicalsChart ›
ProfitabilityGrowthCreditLiquidityWorking capitalDividend yieldDuPontCAGR
Per cent unless marked ×
Tap a line for its trendFY26Mar 2026FY25Mar 2025FY24Mar 2024FY22 and earlierAlpha Plus
+4.5%+32.8%−38.6%
FY22 and earlierEvery year the company has filed comes with Alpha Plus.
+23.6%+804.0%−105.9%
+66.1%+130.8%−142.6%
+371.1%+90.0%−144.6%
+369.0%+89.9%−144.6%
−2.1%+1.5%−4.9%
+1.9%−0.8%−8.5%
+234.9%−73.5%+22.1%
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

MOL₹55.04

Meghmani Organics Limited

· Chemicals
₹ CrorePeersIPLPUNJABCHEMINSECTICIDASTECBHARATRASDHARMAJGSPCROPADVANCEMcap ₹1,400 Cr
ProfitabilityGrowthCreditLiquidityWorking CapitalYield AnalysisDuPont
Ratios — % unless marked ×
12 Months Ending
FY23
31/03/2023
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Revenue Growth—-38.6+32.8+4.5—
EBITDA Growth—-105.9+804.0+23.6—
EBIT Growth—-142.6+130.8+66.1—
Net Income Growth—-144.6+90.0+371.1—
EPS Growth—-144.6+89.9+369.0—
Total Assets Growth—-4.9+1.5-2.1—
Total Equity Growth—-8.5-0.8+1.9—
Cash from Operations Growth—+22.1-73.5+234.9—
No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.